Regardless of the mode of transport, it should be possible to demonstrate that the veterinary medicinal products have not been exposed to conditions that may compromise their quality and integrity. A risk-based approach should be used when planning transport of and for transporting veterinary medicinal products.
Recital 20, Regulation (EU) 2021/1248
In forcesince 29 Jul 2021